Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice
The article focuses on differential choice of ACE inhibitor in clinical practice. Mechanisms of action common for all drugs in this group, indications and benefits are described. Differences in pharmacokinetic features, RAAS blockade, additional unique attributes, indications and strength of evidenc...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2013-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1102 |
id |
doaj-b79093881f5b408792f414d7d129f4fe |
---|---|
record_format |
Article |
spelling |
doaj-b79093881f5b408792f414d7d129f4fe2021-07-28T13:29:14ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902013-12-0109444910.21518/2079-701X-2013-9-44-491102Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choiceO. D. Ostroumova0G. N. Schukina1V. M. Fomina2MSUMD named after A.I. Evdokimov, First MSMU named after I.M.SechenovMSUMD named after A.I. Evdokimov, First MSMU named after I.M.SechenovMSUMD named after A.I. Evdokimov, First MSMU named after I.M.SechenovThe article focuses on differential choice of ACE inhibitor in clinical practice. Mechanisms of action common for all drugs in this group, indications and benefits are described. Differences in pharmacokinetic features, RAAS blockade, additional unique attributes, indications and strength of evidence for the class representative ramipril are highlighted. There is clinical data of Russian studies on anti-hypertensive effectiveness and anti-atherosclerotic properties of Hartil® (ramipril,"EGIS", Hungary).https://www.med-sovet.pro/jour/article/view/1102hypertensionatherosclerosiscoronary heart diseasestrokeace inhibitorsramipril |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
O. D. Ostroumova G. N. Schukina V. M. Fomina |
spellingShingle |
O. D. Ostroumova G. N. Schukina V. M. Fomina Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice Медицинский совет hypertension atherosclerosis coronary heart disease stroke ace inhibitors ramipril |
author_facet |
O. D. Ostroumova G. N. Schukina V. M. Fomina |
author_sort |
O. D. Ostroumova |
title |
Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice |
title_short |
Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice |
title_full |
Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice |
title_fullStr |
Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice |
title_full_unstemmed |
Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice |
title_sort |
angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. how to make the right choice |
publisher |
Remedium Group LLC |
series |
Медицинский совет |
issn |
2079-701X 2658-5790 |
publishDate |
2013-12-01 |
description |
The article focuses on differential choice of ACE inhibitor in clinical practice. Mechanisms of action common for all drugs in this group, indications and benefits are described. Differences in pharmacokinetic features, RAAS blockade, additional unique attributes, indications and strength of evidence for the class representative ramipril are highlighted. There is clinical data of Russian studies on anti-hypertensive effectiveness and anti-atherosclerotic properties of Hartil® (ramipril,"EGIS", Hungary). |
topic |
hypertension atherosclerosis coronary heart disease stroke ace inhibitors ramipril |
url |
https://www.med-sovet.pro/jour/article/view/1102 |
work_keys_str_mv |
AT odostroumova angiotensinconvertingenzymeinhibitorsintreatmentpracticesimilarityanddifferencehowtomaketherightchoice AT gnschukina angiotensinconvertingenzymeinhibitorsintreatmentpracticesimilarityanddifferencehowtomaketherightchoice AT vmfomina angiotensinconvertingenzymeinhibitorsintreatmentpracticesimilarityanddifferencehowtomaketherightchoice |
_version_ |
1721274757295374336 |